Insulet corporation stock
Insulet Corporation’s stock is NA in 2023, NA in the previous five trading days and down 35.8% in the past year. Currently, Insulet Corporation’s price-earnings ratio is 115.0. Insulet Corporation’s trailing 12-month revenue is $1.6 billion with a 7.7% net profit margin. Year-over-year quarterly sales growth most recently was 27.0%.Insulet Corporation quote is equal to 187.950 USD at 2023-11-27. Based on our forecasts, a long-term increase is expected, the "PODD" stock price prognosis for ...Insulet Corporation’s market capitalization currently stands at $19.43 billion with a price-to-earnings (P/E) ratio of 246.12 and a price/earnings-to-growth (PEG) ratio of 5.96. The relatively high P/E ratio suggests that the stock is trading at a premium compared to its earnings, while the PEG ratio indicates potentially overpriced growth ...
Did you know?
ACTON, Mass., November 02, 2023--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today ...Insulet Corporation stock has a Value Score of 2, Growth Score of 75 and Estimate Revisions Score of 73. Comparing STAAR Surgical Co and Insulet Corporation’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well ...Get the latest Insulet Corporation (GOV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Insulet Corporation : Chart with news and technical impact analysis of markets informations on Insulet Corporation quotes | BOERSE MUENCHEN: GOV | BOERSE MUENCHENACTON, Mass. & MILPITAS, Calif.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, and Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced Insulet has acquired assets related to Bigfoot’s pump-based automated insulin ...ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended March 31, 2023.In February of last year, Insulet posted a 21% increase in sales to $1.10 billion, as operating earnings rose 144% to $126 million. GAAP earnings only came in at $17 million, or $0.24 per share ...
Insulet Corporation (PODD) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 158.27 -4.31 (-2.65%) As of 01:16PM EST. Market open. 1d. 5d.Sep 12, 2023 · The stock carries a Zacks Rank #3 (Hold). Insulet has been progressing well with respect to its four-pillar strategy, where the first two pillars include expanding access and awareness and ... ….
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Insulet corporation stock. Possible cause: Not clear insulet corporation stock.
See the latest Insulet Corp stock price (PODD:XNAS), related news, valuation, dividends and more to help you make your investing decisions.US45784P1012. Market Closed - Nasdaq. Other stock markets. 04:00:00 2023-11-27 pm EST. 5-day change. 1st Jan Change. 187.74 USD.The stock carries a Zacks Rank #3 (Hold). Insulet has been progressing well with respect to its four-pillar strategy, where the first two pillars include expanding access and awareness and ...
Insulet Corporation is an innovative medical device company based in Acton, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through our revolutionary Omnipod Insulin Management System, we seek to expand the use of insulin pump therapy. Learn More.Insulet Corporation Follow Share $192.19 After Hours: $192.19 (0.00%) 0.00 Closed: Dec 1, 4:03:57 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Medtronic PLC $79.99 MDT0.96% DexCom,...
1964 kennedy half dollar value uncirculated Mar 18, 2023 · Insulet Corporation (PODD) is a leading medical device company that is dedicated to creating advanced insulin delivery systems for individuals with diabetes. Their flagship product is designed to ... best place to sell used iphonedodge cox income fund Sep 12, 2023 · The stock carries a Zacks Rank #3 (Hold). Insulet has been progressing well with respect to its four-pillar strategy, where the first two pillars include expanding access and awareness and ... Get the latest Insulet Corporation (PODD) real-time quote, historical performance, charts, and other financial information to help you make more informed ... best va loans Insulet Corporation : News, information and stories for Insulet Corporation | Nasdaq: PODD | NasdaqInsulet Corporation’s current trading price is -58.02% away from its 52-week high, while its distance from the 52-week low is 12.06%. The stock’s price range for this time frame has been between $125.82 and $335.91. The trading volume of the company’s shares in the Healthcare reached around 1.13 million for the day, which was evidently ... best tangible investmentsfha mortgage rates azhouston financial advisors Insulet Corporation specializes in the design, manufacture and marketing of medical devices intended to improve the lives of people with insulin-dependent diabetes. In addition, the group offers non-insulin subcutaneous drug delivery systems used in several therapeutic areas. what is the best trading platform for day traders Oct 20, 2023 · Insulet Corporation (PODD) : Free Stock Analysis Report Catalyst Pharmaceuticals, Inc. (CPRX) : Free Stock Analysis Report Spero Therapeutics, Inc. (SPRO) : Free Stock Analysis Report mint vs empowerrvmdmeta dividend Oct 4, 2023 · PODD stock, the ticker symbol for Insulet Corp, has been performing well in recent months and is expected to continue its upward trajectory. According to data from CNN Money, the 18 analysts offering 12-month price forecasts for Insulet Corp have a median target of $280.00, with a high estimate of $360.00 and a low estimate of $185.00. Copart, Inc. (CPRT) : Free Stock Analysis Report. Insulet Corporation (PODD) : Free Stock Analysis Report. Vertiv Holdings Co. (VRT) : Free Stock Analysis …